Literature DB >> 23907122

Cyclin I is involved in the regulation of cell cycle progression.

Taiki Nagano1, Toshiaki Hashimoto, Akio Nakashima, Shin-ichi Hisanaga, Ushio Kikkawa, Shinji Kamada.   

Abstract

Cyclins control cell cycle progression by regulating the activity of cyclin-dependent kinases (Cdks). Cyclin I is a member of the cyclin family because of the presence of a cyclin box motif. It has been suggested that Cyclin I is involved in various biological processes, such as cell survival, angiogenesis, and cell differentiation. However, whether or not Cyclin I has a role in regulating the cell cycle similarly to other cyclins has yet to be clarified. Therefore, we investigated the role for Cyclin I in cell cycle progression. We showed that the protein level of Cyclin I oscillated during the cell cycle, and that Cyclin I was subjected to ubiquitination and degradation in cells. The interaction between Cyclin I and Cdk5 was detected in cells overexpressed with both proteins. Furthermore, depletion of Cyclin I by siRNAs prevented cell proliferation, suggesting the positive role of Cyclin I for the cell cycle progression. In addition, flow cytometric analysis revealed that cells depleted of Cyclin I were accumulated at G₂/M phases. By using HeLa.S-Fucci (fluorescent ubiquitination-based cell cycle indicator) cells, we further confirmed that knockdown of Cyclin I induced cell cycle arrest at S/G₂/M phases. These results strongly suggest that Cyclin I has the role in the regulation of cell cycle progression.

Entities:  

Keywords:  Cdk5; Fucci; cell proliferation; cyclin I; ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 23907122      PMCID: PMC3865051          DOI: 10.4161/cc.25623

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

Review 1.  Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.

Authors:  Shin-ichi Hisanaga; Ryo Endo
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

2.  Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex.

Authors:  Jie Zhang; Huifang Li; Odessa Yabut; Haley Fitzpatrick; Gabriella D'Arcangelo; Karl Herrup
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

3.  Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart.

Authors:  Ye Liu; Mei Kuen Tang; Dong Qing Cai; Ming Li; Wan Man Wong; Pak Ham Chow; Kenneth K H Lee
Journal:  Proteomics       Date:  2007-01       Impact factor: 3.984

4.  Cyclin I protects podocytes from apoptosis.

Authors:  Siân V Griffin; J Paul Olivier; Jeffrey W Pippin; James M Roberts; Stuart J Shankland
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

5.  Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.

Authors:  Guoxiong Xu; Stefanie Bernaudo; Guodong Fu; Daniel Y Lee; Burton B Yang; Chun Peng
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

6.  Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.

Authors:  Mari Yamada; Taro Saito; Yutaka Sato; Yusei Kawai; Akio Sekigawa; Yuko Hamazumi; Akiko Asada; Mitsuhito Wada; Hirofumi Doi; Shin-Ichi Hisanaga
Journal:  J Neurochem       Date:  2007-03-29       Impact factor: 5.372

7.  Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.

Authors:  Akiko Asada; Naoyuki Yamamoto; Masaki Gohda; Taro Saito; Nobuhiro Hayashi; Shin-Ichi Hisanaga
Journal:  J Neurochem       Date:  2008-05-26       Impact factor: 5.372

8.  A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1.

Authors:  Denise M Piscopo; Philip W Hinds
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

9.  Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons.

Authors:  Jie Zhang; Samantha A Cicero; Li Wang; Rita R Romito-Digiacomo; Yan Yang; Karl Herrup
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

10.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

View more
  9 in total

1.  Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Authors:  Hiroyuki Kobayashi; Taro Saito; Ko Sato; Kotaro Furusawa; Tomohisa Hosokawa; Koji Tsutsumi; Akiko Asada; Shinji Kamada; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

Review 2.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

3.  Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients.

Authors:  Sara Chiker; Vincent Pennaneach; Damarys Loew; Florent Dingli; Denis Biard; Fabrice P Cordelières; Simon Gemble; Sophie Vacher; Ivan Bieche; Janet Hall; Marie Fernet
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells.

Authors:  Julia Lindqvist; Susumu Y Imanishi; Elin Torvaldson; Marjo Malinen; Mika Remes; Fanny Örn; Jorma J Palvimo; John E Eriksson
Journal:  Mol Biol Cell       Date:  2015-04-07       Impact factor: 4.138

5.  Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation.

Authors:  Chengcheng Liu; Xiaoyan Zhai; Bin Zhao; Yanfei Wang; Zhigang Xu
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

6.  Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling.

Authors:  Xiang Li; Jiepeng Huang; Tingting Yu; Xiaoting Fang; Liqin Lou; Shijun Xin; Ling Ji; Feizhao Jiang; Yongliang Lou
Journal:  Front Microbiol       Date:  2021-01-06       Impact factor: 5.640

7.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16

Review 8.  The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.

Authors:  Balbina García-Reyes; Anna-Laura Kretz; Jan-Philipp Ruff; Silvia von Karstedt; Andreas Hillenbrand; Uwe Knippschild; Doris Henne-Bruns; Johannes Lemke
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

9.  CCNI2 plays a promoting role in the progression of colorectal cancer.

Authors:  Dong-Ming Lai; Jiang-Jiang Bi; Yong-Hui Chen; Yu-Di Wu; Qing-Wen Huang; Hai-Jie Li; Sheng Zhang; Zheng Fu; Yi-Xin Tong
Journal:  Cancer Med       Date:  2021-02-23       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.